Risperdal Caused Teen Boy's Breast Growth, Jury Hears

Law360, Philadelphia (September 24, 2012, 7:12 PM EDT) -- A teenage boy grew breasts after years of ingesting Risperdal, an antipsychotic drug developed by a Johnson & Johnson subsidiary and illegally promoted for use in children despite studies showing the risk of side effects, the boy's attorney told a jury in a Philadelphia courtroom Monday.

In opening arguments in the Philadelphia Court of Common Pleas, an attorney for Andrew Bentley told the jurors that Ortho-McNeil-Janssen Pharmaceuticals Inc. engaged in a nationwide campaign to promote the drug for off-label use in children despite knowing that it...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.